Company intelligence / Profile preview
Nano PharmaSolutions
- Ownership
- Private
- Development stage
- Preclinical
Overview
Nano PharmaSolutions has developed a proprietary, chemical-free nanoformulation platform that increases the solubility and bioavailability of poorly soluble small molecule drugs. The company collaborates with pharma partners to apply its technology to both approved and investigational compounds. No clinical results reported as the focus is on enabling technologies rather than direct drug development.
- Modalities
- NanoparticleSmall molecule
- Industry
- Drug Discovery Services
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Nano PharmaSolutions.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nano PharmaSolutions.